Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease.
about
Protease inhibition as new therapeutic strategy for GI diseasesSystematic approaches to identify E3 ligase substratesMDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesisRecent advances in adherence and invasion of pathogenic Escherichia coliUnderstanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.Helicobacter pylori infection and inflammatory bowel disease: is there a link?Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease.CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier.Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli.Glutamine enema regulates colonic ubiquitinated proteins but not proteasome activities during TNBS-induced colitis leading to increased mitochondrial activity.Crohn's disease and sarcoidosis in siblings: follow-up of a published report with a new case and brief review of the literature.Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis - a short report.Importance of Validating Antibodies and Small Compound Inhibitors Using Genetic Knockout Studies-T Cell Receptor-Induced CYLD Phosphorylation by IKKε/TBK1 as a Case Study.Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease.
P2860
Q26747722-A8CF738A-79E8-4299-8D5B-B51FE802C5B9Q28068398-6B0B6831-4F37-4150-835C-322604B56DCCQ33884295-E32BE4D9-16DF-484E-ADBD-C2F9E8D9F57CQ34429054-E9BA7839-6A7C-4F76-8ED5-992BFE453ECFQ34786166-69C387AA-6F67-4F2F-83B3-1E4DA17261EAQ35271319-08E52D72-C81C-4B7F-AB96-707C8BBE322EQ35745630-39D23FA8-E343-4EEB-AB83-C6E19C938743Q36212145-A7D9C142-D94E-42D2-A3DB-2DBDF020571AQ38219027-C778C970-6EBA-4FD9-9F17-D97808C08E8BQ39002865-CF20E3E0-5FD0-4260-B28F-E1B7479BA211Q39210955-599B3F09-F6F3-490D-8074-6A854977AC6BQ39388017-5640E9F5-2094-4E94-A811-2CFD08D90AF2Q41721216-6B1238BB-3CFF-4818-B873-1C66C4528802Q48324393-389F5748-0B13-4648-BB63-3944998932DEQ50282060-D194BDE6-0539-4A98-A17E-2A6E4559FEA4Q53203833-694FFCC2-33D2-43DF-8E65-5A1DCF40C921Q54110117-1EF0741A-62FC-44C3-995B-D0812221F239Q55268565-35DB0A5A-E0A7-4533-ADC9-AA3B6C1DBF40
P2860
Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genetic and microbial factors ...... in inflammatory bowel disease.
@en
type
label
Genetic and microbial factors ...... in inflammatory bowel disease.
@en
prefLabel
Genetic and microbial factors ...... in inflammatory bowel disease.
@en
P2093
P2860
P50
P1433
P1476
Genetic and microbial factors ...... in inflammatory bowel disease.
@en
P2093
Atilla Tordai
Daniel Lottaz
Daniel W Hommes
Dominiek Staelens
Emilie Vazeille
Frank Seibold
Gert De Hertogh
Hein W Verspaget
Isabelle Cleynen
Jestinah M Mahachie John
P2860
P304
P356
10.1136/GUTJNL-2012-303205
P407
P50
P577
2013-10-03T00:00:00Z